Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Qual Life Res. 2018 Sep 15;28(1):47–56. doi: 10.1007/s11136-018-2002-5

Table 3.

Patient Clinical Data

Clinical Data Patient (N=223) N (%)
Source of Transmission
 Behaviorally Infected 156 (70.0)
 Perinatally Infected 6 (2.7)
 Unknown 61 (27.4)
Time Since Diagnosis of HIV positive (years)
 Mean (SD) 17.5 (8.2)
CD4 Count <200
 Yes 21 (9.8)
 No 193 (90.2)
Advance Directive in Chart
 Yes 29 (13.3)
 No 178 (81.7)
Is patient prescribed HIV medication?
 Yes 208 (94.6)
 No 12 (5.5)
Adherence Score
 ⩾90% 171 (81.4)
 <90% 39 (18.6)
Viral load undetectable (<50)
 Yes 167 (75.2)
 No 55 (24.8)
Dialysis
 Yes 6 (2.7)
 No 213 (97.3)
Currently drug and/or alcohol dependent
 Yes 9 (4.1)
 No 212 (95.9)
Current cigarette smoker
 Yes 82 (36.9)
 No 140 (63.1)
Comorbidities
 Liver Disease including Hepatitis B & Hepatitis C 63 (28.3)
 Diabetes 35 (15.7)
 Cancer or malignancies 25 (11.2)
 Heart disease or heart failure including heart attack or stroke 25 (11.2)
 Renal disease (kidney disease) 18 (8.1)
 HIV Associated Neurocognitive Disorder (HAND) 3 (1.3)
a.

This table describes the clinical information about the patients in the FACE ACP clinical trial for adult PLWH.